Analysis of blood clearance and labeled metabolites for the estrogen receptor tracer [F-18]-16α-Fluorestradiol (FES)

This publication has 13 references indexed in Scilit:

• The use of 3-methoxymethyl-16β, 17β-epiestriol-O-cyclic sulfone as the precursor in the synthesis of F-18 16α-fluoroestradiol
  Nuclear Medicine and Biology, 1996
• Current status of adjuvant systemic therapy for primary breast cancer: progress and controversy
  CA: A Cancer Journal for Clinicians, 1995
• Titration of the in vivo uptake of 16α-[18F]fluoroestradiol by target tissues in the rat: Competition by tamoxifen, and implications for quantitating estrogen receptors in vivo and the use of animal models in receptor-binding radiopharmaceutical development
  Nuclear Medicine and Biology, 1993
• The plasma sex steroid binding protein (SBP or SHBG). A critical review of recent developments on the structure, molecular biology and function
  The Journal of Steroid Biochemistry and Molecular Biology, 1991
• Endocrine Treatment of Breast Cancer in Women
  Endocrine Reviews, 1990
• Oestrogen receptor status of primary breast carcinomas and their metastases. Relation to pattern of spread and survival after recurrence
  British Journal of Cancer, 1989
• Breast cancer: PET imaging of estrogen receptors.
  Radiology, 1988
• Immunocytochemical assay for estrogen receptor in patients with breast cancer: relationship to a biochemical assay and to outcome of therapy.
  Journal of Clinical Oncology, 1986
• QUANTITATIVE OESTRADIOL RECEPTOR VALUES IN PRIMARY BREAST CANCER AND RESPONSE OF METASTASES TO ENDOCRINE THERAPY
  The Lancet, 1981
• Absolute Cross Sections for the Production of ¹⁸F via the ¹⁸O(p, n)¹⁸F Reaction
  Radiochimica Acta, 1979